Interleukin-2 Therapy of Metastatic Renal Cell Carcinoma: Update of Phase III Trials-Reference-Cited by-同舟云学术

Interleukin-2 Therapy of Metastatic Renal Cell Carcinoma: Update of Phase III Trials

Published:2006-09 Issue:2 Volume:5 Page:114-119
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

McDermott David F.,Regan Meredith M.,Atkins Michael B.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference43 articles.

1. Cancers of the kidney;Linehan,2005

2. Renal-cell carcinoma;Cohen;N Engl J Med,2005

3. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma;Motzer;J Clin Oncol,1999

4. Cytotoxic chemotherapy for advanced renal cell carcinoma;Yagoda;Urol Clin North Am,1993

5. Recombinant interferon alfa-2a with vinblastine vs. vinblastine alone in advanced renal cell carcinoma: a phase III study;Pyrhonen;Proc Am Soc Clin Oncol,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia;Immunology;2022-09-03

2. Retraction: “Immunotherapy of metastatic renal cell carcinoma” by McDermott DF;Cancer;2019-05-08

3. Rational design and development of a peptide inhibitor for the PD-1/PD-L1 interaction;Cancer Letters;2018-10

4. Retraction: Update on the Application of Interleukin-2 in the Treatment of Renal Cell Carcinoma;Clinical Cancer Research;2018-07-31

5. The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition;Journal of Kidney Cancer and VHL;2017-05-11